AEON Biopharma, Inc. (AEON) Free cash flow 2022–2025
AEON Biopharma, Inc. (AEON) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$17.3MFY2025 · since FY2022: -$35.9M → -$17.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$17.3M | — |
| FY2022 | -$35.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More AEON financial trends
AEON RevenueAEON Net incomeAEON Net marginAEON Gross profitAEON Gross marginAEON Operating incomeAEON Operating marginAEON Operating cash flowAEON Capital expendituresAEON Return on equityAEON Stock buybacksAEON Dividends paidAEON Total assetsAEON Total liabilitiesAEON Shareholders’ equityAEON overview →